Teladoc Health showed strong financial performance and progress in product innovation and international expansion. However, challenges in the BetterHelp segment and chronic care enrollment, along with increased customer acquisition costs, presented significant hurdles.

Company Guidance

During Teladoc Health's second quarter 2025 earnings call, the company provided updates on their financial metrics and strategic initiatives. The reported consolidated revenue was $631.9 million, down 1.6% year-over-year, with adjusted EBITDA reaching $69.3 million, representing an 11% margin. The net loss per share was $0.19, a significant improvement from a $4.92 loss in the same quarter of 2024. Free cash flow for the quarter was $61 million, with cash and cash equivalents standing at $680 million. The Integrated Care segment saw a revenue increase of 3.7% to $391.5 million, while BetterHelp's revenue was $240.4 million. The company narrowed its 2025 consolidated revenue guidance to $2.501 billion to $2.548 billion and adjusted EBITDA to $263 million to $294 million. They also highlighted strategic initiatives, including the launch of Wellbound, an employee assistance program, and advancements in their cardiometabolic health program. Additionally, they discussed progress in their international segment, which now accounts for over 15% of consolidated revenue, and their strategic focus on enhancing their integrated care offerings, leveraging their mental health position, and operational excellence.

Strong Financial Performance

Second quarter consolidated revenue was $631.9 million, near the high end of the guidance range, and adjusted EBITDA of $69.3 million was also at the upper end of the guidance range, representing a margin of 11%.

Integrated Care Segment Growth

Integrated Care segment revenue grew by 3.7% year-over-year to $391.5 million, exceeding the high end of the guidance range. U.S. Integrated Care segment membership increased by 11% year-over-year.

Product Innovation and Launches

Launched Wellbound, a new employee assistance program, and enhanced cardiometabolic health programs with new features. Also launched an AI-enabled virtual sitter solution for hospitals.

International Business Expansion

International Integrated Care business delivered mid-teens growth on a constant currency basis, now accounting for over 15% of consolidated revenue.

BetterHelp Insurance Initiative

BetterHelp's insurance coverage initiative launched in one state with encouraging early results, aiming to leverage BetterHelp's strong consumer activation for growth.

Teladoc (TDOC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TDOC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	-0.26 / -	-0.19	―	―	―
Jul 29, 2025	2025 (Q2)	-0.26 / -0.19	-4.92	96.14% (+4.73)
Apr 30, 2025	2025 (Q1)	-0.34 / -0.53	-0.49	-8.16% (-0.04)
Feb 26, 2025	2024 (Q4)	-0.26 / -0.28	-0.17	-64.71% (-0.11)
Oct 30, 2024	2024 (Q3)	-0.28 / -0.19	-0.35	45.71% (+0.16)
Jul 31, 2024	2024 (Q2)	-0.34 / -4.92	-0.4	-1130.00% (-4.52)
Apr 25, 2024	2024 (Q1)	-0.46 / -0.49	-0.42	-16.67% (-0.07)
Feb 20, 2024	2023 (Q4)	-0.22 / -0.17	-23.49	99.28% (+23.32)
Oct 24, 2023	2023 (Q3)	-0.36 / -0.35	-0.45	22.22% (+0.10)
Jul 25, 2023	2023 (Q2)	-0.41 / -0.40	-19.22	97.92% (+18.82)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TDOC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 29, 2025	$7.53	$7.40	-1.73%
Apr 30, 2025	$7.19	$6.99	-2.78%
Feb 26, 2025	$10.99	$9.50	-13.56%
Oct 30, 2024	$8.86	$9.00	+1.58%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.